Unknown

Dataset Information

0

Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.


ABSTRACT:

Importance

Extremely low diastolic blood pressure has been reported to be associated with increased adverse cardiovascular events (ie, the diastolic J-shape phenomenon); however, current US guidelines recommend an intensive blood pressure target of less than 130/80 mm Hg without mentioning the lower limits of diastolic blood pressure.

Objectives

To evaluate whether there is a diastolic J-shape phenomenon for patients with an treated systolic blood pressure of less than 130 mm Hg and to explore the safe and optimal diastolic blood pressure ranges for this patient population.

Design, setting, and participants

This cohort study analyzed outcome data of patients at high cardiovascular risk who were randomized to intensive or standard blood pressure control and achieved treated systolic blood pressure of less than 130 mm Hg in the Systolic Blood Pressure Intervention Trial (SPRINT) and Action to Control Cardiovascular Risk in Diabetes-Blood Pressure (ACCORD-BP) trial. Data were collected from October 2010 to August 2015 (SPRINT) and from September 1999 to June 2009 (ACCORD-BP). Data were analyzed from January to May 2020.

Exposure

Treated diastolic blood pressure, divided in intervals of less than 60, 60 to less than 70, 70 to less than 80, and 80 mm Hg and greater.

Main outcomes and measures

The primary outcome was a composite of all-cause death, nonfatal myocardial infarction, and nonfatal stroke. A composite cardiovascular outcome, including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke, was among the key secondary outcomes.

Results

A total of 7515 patients (mean [SD] age, 65.6 [8.7] years; 4553 [60.6%] men) were included in this analysis. The nominally lowest risk was observed at a diastolic blood pressure between 70 and 80 mm Hg for the primary outcome, the composite cardiovascular outcome, nonfatal myocardial infarction, and cardiovascular death. A mean diastolic blood pressure of less than 60 mm Hg was associated with significantly increased risk of the primary outcome (hazard ratio [HR], 1.46; 95% CI, 1.13-1.90; P?=?.004), the composite cardiovascular outcome (HR, 1.74; 95% CI, 1.26-2.41; P?=?.001), nonfatal myocardial infarction (HR, 1.73; 95% CI, 1.15-2.59; P?=?.008), and nonfatal stroke (HR, 2.67; 95% CI, 1.26-5.63; P?=?.01).

Conclusions and relevance

This cohort study found that lowering diastolic blood pressure to less than 60 mm Hg was associated with increased risk of cardiovascular events in patients with high cardiovascular risk and an treated systolic blood pressure less than 130 mm Hg. The finding that a diastolic blood pressure value between 70 and 80 mm Hg was an optimum target for this patient population merits further study.

SUBMITTER: Li J 

PROVIDER: S-EPMC7890449 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.

Li Jingen J   Somers Virend K VK   Gao Xiang X   Chen Zhuo Z   Ju Jianqing J   Lin Qian Q   Mohamed Essa A EA   Karim Shahid S   Xu Hao H   Zhang Lijing L  

JAMA network open 20210201 2


<h4>Importance</h4>Extremely low diastolic blood pressure has been reported to be associated with increased adverse cardiovascular events (ie, the diastolic J-shape phenomenon); however, current US guidelines recommend an intensive blood pressure target of less than 130/80 mm Hg without mentioning the lower limits of diastolic blood pressure.<h4>Objectives</h4>To evaluate whether there is a diastolic J-shape phenomenon for patients with an treated systolic blood pressure of less than 130 mm Hg a  ...[more]

Similar Datasets

| S-EPMC8689269 | biostudies-literature
| S-EPMC7585965 | biostudies-literature
| S-EPMC4752407 | biostudies-literature
| S-EPMC10749049 | biostudies-literature
| S-EPMC8030568 | biostudies-literature
| S-EPMC10620971 | biostudies-literature
| S-EPMC5580500 | biostudies-literature
| S-EPMC10513918 | biostudies-literature
| S-EPMC4459970 | biostudies-literature
| S-EPMC7309297 | biostudies-literature